Finch Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$40.5M
Industry:Biotech
Founded:N/A
Lead Investor(s):N/A

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Finch Therapeutics's estimated annual revenue is currently $21.1M per year.
  • Finch Therapeutics received $36.0M in venture funding in March 2018.
  • Finch Therapeutics's estimated revenue per employee is $155,000
  • Finch Therapeutics's total funding is $40.5M.

Employee Data

  • Finch Therapeutics has 136 Employees.
  • Finch Therapeutics grew their employee count by 45% last year.
  • Finch Therapeutics currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingPricing
Ultivue
$8.7M56-12%N/AN/A
Ohana Bioscienc...
$8.7M5660%N/AN/A
Compass Therape...
$16.4M10614%N/AN/A
Cell Signaling ...
$89.4M577N/AN/AN/A
Momenta Pharmac...
N/A220N/AN/AN/A
Emulate
$15.3M99-17%N/AN/A
ArQule
N/A94N/AN/AN/A
Hamilton Storag...
$17.2M1119%N/AN/A
Alnylam Pharmac...
$74.9M127731%N/AN/A
Transgenomic
N/A47N/AN/AN/A
Missing a competitor? Contribute!?
Submit

Finch Therapeutics is unlocking the therapeutic potential of the microbiome through our human-first discovery platform. We use machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. This human-centric discovery model leverages clinical data to focus our in-vitro and in-vivo efforts on cocktails of microbes that have already demonstrated safety and efficacy in humans. This enables early retirement of translational risk and avoids the challenges of extrapolating host-specific effects from animal models. Our team values transparency, integrity, humility, and collaboration, and we intend to have fun while maximizing our ability to make an impact on patients lives.

keywords:N/A

136

Number of Employees

$21.1M

Revenue (est)

1

Current Jobs

45%

Employee Growth %

$40.5M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Sonia TimberlakeVp Research
Tulan KantesariaAP & Procurement manager / Senior Accountant (Contract)
Josh GrehanSenior Manager Of Business OperationsEmail Available
Thomas SmithResearch and Development Operations Manager
Elyse SkenderianClinical Trial Manager
Natalia OutkinaSenior Accounting Manager
Yu YangSenior Scientist, manager
Kristyn BogliAssociate Director, Program Management
Zeba JamshedSenior Program Manager, Cmc
Crystal ChenSr Medical Director

Finch Therapeutics News

09/03/2019 - Finch Therapeutics bags $53m for microbiome therapies

Finch Therapeutics has completed a Series C financing, raising $53m to advance its microbiome therapies pipeline. The Massachusetts-based ...

09/08/2019 - Finch Therapeutics Raises $53 Million to Advance ...

Finch Therapeutics Raises $53 Million to Advance Microbiome-Based Therapies for Recurrent C. Difficile, Autism and other Disease Areas.

09/03/2019 - Finch Therapeutics Raises $53M in Series C Funding

Finch Therapeutics Group, Inc., a Somerville, MA-based clinical-stage microbiome therapeutics company, completed a $53m Series C ...

Finch Therapeutics Funding

DateAmountRoundLead InvestorsReference
2018-03-02$36.0MBMultipleArticle

Finch Therapeutics Executive Hires

DateNameTitleReference
2018-06-13Ulrich ThienelChief Medical OfficerArticle

Finch Therapeutics Acquisitions

DateCompany NameAmountNotesReference
2017-10-24CrestovoArticle